How to keep muscle on a GLP-1
GLP-1 medications make weight loss easier. Keeping the weight you lose mostly fat takes a little extra work.
Short answer
On semaglutide or tirzepatide, roughly a quarter to two-fifths of weight lost in trials was lean mass. To keep more muscle: strength train two to three times a week, eat enough protein (ask your clinician for a target; 1.2–1.6 g per kg is commonly discussed), and track waist, arms and shoulders with matched photos so you can see whether you’re losing fat or muscle. Talk to your prescriber before changing diet or exercise.
What the trials found
In the STEP 1 DXA substudy, about 40% of weight lost on semaglutide was lean mass; in SURMOUNT-1, about a quarter on tirzepatide. Lean mass includes water and organs, so muscle loss is lower than these figures, but the trend is why clinicians emphasise strength training.
A practical routine
- Two or three full-body strength sessions a week, focusing on big movements.
- Protein at every meal, even when appetite is low.
- A weekly check-in on injection day: weight, waist, front and side photos.
- Arms, shoulders and thighs every two to four weeks.
Warning signs
Strength falling week after week, arms and shoulders shrinking as fast as your waist, or weight dropping faster than about 1% a week for a long time. Check with the fat vs muscle loss calculator and speak to your clinician. ProgressLens watches for exactly this pattern: its AI report has a muscle-loss signal built for GLP-1 users.
See also: Ozempic, Mounjaro, Zepbound: fat or muscle? · Semaglutide vs tirzepatide muscle loss
FAQ
Frequently asked questions
Do you lose muscle on Ozempic?
Some lean mass loss happens with any significant weight loss, including on semaglutide. Strength training and protein reduce it.
Should I lift weights on Mounjaro?
Most clinicians encourage it to help preserve muscle. Ask yours about what’s right for you.
Sources
- Wilding JPH et al. (2021). STEP 1. N Engl J Med 384:989–1002 (DXA substudy).
- Jastreboff AM et al. (2022). SURMOUNT-1. N Engl J Med 387:205–216.